• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

除BRCA1和BRCA2之外的与乳腺癌易感性相关的基因。

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

作者信息

de Jong M M, Nolte I M, te Meerman G J, van der Graaf W T A, Oosterwijk J C, Kleibeuker J H, Schaapveld M, de Vries E G E

机构信息

Department of Medical Oncology, University Hospital, Groningen, The Netherlands.

出版信息

J Med Genet. 2002 Apr;39(4):225-42. doi: 10.1136/jmg.39.4.225.

DOI:10.1136/jmg.39.4.225
PMID:11950848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1735082/
Abstract

This review focuses on genes other than the high penetrance genes BRCA1 and BRCA2 that are involved in breast cancer susceptibility. The goal of this review is the discovery of polymorphisms that are either associated with breast cancer or that are in strong linkage disequilibrium with breast cancer causing variants. An association with breast cancer at a 5% significance level was found for 13 polymorphisms in 10 genes described in more than one breast cancer study. Our data will help focus on the further analysis of genetic polymorphisms in populations of appropriate size, and especially on the combinations of such polymorphisms. This will facilitate determination of population attributable risks, understanding of gene-gene interactions, and improving estimates of genetic cancer risks.

摘要

本综述聚焦于除高外显率基因BRCA1和BRCA2之外的、与乳腺癌易感性相关的基因。本综述的目的是发现与乳腺癌相关的多态性,或与导致乳腺癌的变异处于强连锁不平衡状态的多态性。在不止一项乳腺癌研究中描述的10个基因中的13个多态性中,发现了与乳腺癌的关联,显著性水平为5%。我们的数据将有助于集中对适当规模人群中的基因多态性进行进一步分析,特别是对这些多态性的组合进行分析。这将有助于确定人群归因风险,理解基因-基因相互作用,并改进对遗传性癌症风险的估计。

相似文献

1
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.除BRCA1和BRCA2之外的与乳腺癌易感性相关的基因。
J Med Genet. 2002 Apr;39(4):225-42. doi: 10.1136/jmg.39.4.225.
2
Susceptibility to breast cancer: hereditary syndromes and low penetrance genes.乳腺癌易感性:遗传性综合征与低外显率基因
Breast Dis. 2006;27:21-50. doi: 10.3233/bd-2007-27103.
3
[Familial breast cancer, ovarian cancer].[家族性乳腺癌、卵巢癌]
Nihon Rinsho. 2006 Jun 28;Suppl 2:366-70.
4
Practical aspects of genetic counseling in breast cancer: lights and shadows.乳腺癌遗传咨询的实际问题:利弊共存。
Breast. 2013 Aug;22(4):375-82. doi: 10.1016/j.breast.2013.04.006. Epub 2013 May 11.
5
Breast and ovarian cancer genetics and prevention.乳腺癌和卵巢癌遗传学与预防
W V Med J. 2003 Sep-Oct;99(5):187-91.
6
Management of women with a family history of breast cancer.有乳腺癌家族史女性的管理。
Int J Clin Pract. 1999 Apr-May;53(3):192-6.
7
[Genetics and cancer of the breast].[乳腺癌的遗传学与癌症]
Ann Chir. 1994;48(4):303-8.
8
Germ line mutations associated with breast cancer susceptibility.与乳腺癌易感性相关的种系突变。
Eur J Cancer. 2001 Feb;37(3):300-21. doi: 10.1016/s0959-8049(00)00378-6.
9
Hereditary breast cancer.遗传性乳腺癌
Curr Probl Surg. 2001 Jun;38(6):387-480.
10
Genetic heterogeneity in breast cancer susceptibility.乳腺癌易感性中的遗传异质性。
Acta Oncol. 1996;35(4):407-10. doi: 10.3109/02841869609109913.

引用本文的文献

1
Possible Association of Glutathione S-Transferase Pi 1 (GSTP1) Gene Polymorphism in Iraqi Patients with Breast Cancer.伊拉克乳腺癌患者谷胱甘肽S-转移酶Pi 1(GSTP1)基因多态性的可能关联
Rep Biochem Mol Biol. 2025 Jan;13(4):516-524. doi: 10.61186/rbmb.13.4.516.
2
The Spectrum of Genetic Mutations Among Patients with Hereditary Breast and Ovarian Cancer.遗传性乳腺癌和卵巢癌患者的基因突变谱
J Clin Med. 2025 Jun 26;14(13):4536. doi: 10.3390/jcm14134536.
3
Breast cancer in the era of precision medicine.精准医学时代的乳腺癌。
Mol Biol Rep. 2022 Oct;49(10):10023-10037. doi: 10.1007/s11033-022-07571-2. Epub 2022 Jun 22.
4
Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.评价关联研究及 CYP1A1 T3801C 和 A2455G 多态性与乳腺癌风险的系统评价和荟萃分析。
PLoS One. 2021 Apr 28;16(4):e0249632. doi: 10.1371/journal.pone.0249632. eCollection 2021.
5
Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients.乳腺癌体细胞突变图谱:沙特阿拉伯患者靶向治疗的新机遇
Oncotarget. 2021 Mar 30;12(7):686-697. doi: 10.18632/oncotarget.27909.
6
Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level.使用在基因、患者和队列水平执行的多层注释方法解读胰腺导管腺癌易感基因中的序列变异。
Front Oncol. 2021 Mar 5;11:606820. doi: 10.3389/fonc.2021.606820. eCollection 2021.
7
Classification of Homo sapiens gene behavior using linear discriminant analysis fused with minimum entropy mapping.利用线性判别分析与最小熵映射融合的方法对人类基因行为进行分类。
Med Biol Eng Comput. 2021 Mar;59(3):673-691. doi: 10.1007/s11517-021-02324-y. Epub 2021 Feb 17.
8
Tamoxifen exposure in pregnancy after synchronous breast and thyroid cancer.同步性乳腺癌和甲状腺癌后孕期暴露于他莫昔芬的情况。
Ecancermedicalscience. 2020 Oct 15;14:1125. doi: 10.3332/ecancer.2020.1125. eCollection 2020.
9
Molecular Biomarkers for Early Detection and Prevention of Ovarian Cancer-A Gateway for Good Prognosis: A Narrative Review.用于卵巢癌早期检测和预防的分子生物标志物——良好预后的途径:一项叙述性综述
Int J Prev Med. 2020 Sep 3;11:135. doi: 10.4103/ijpvm.IJPVM_75_19. eCollection 2020.
10
Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.个体和联合 GSTM1、GSTT1 和 GSTP1 多态性对乳腺癌风险的影响:系统荟萃分析的荟萃分析和重新分析。
PLoS One. 2020 Mar 10;15(3):e0216147. doi: 10.1371/journal.pone.0216147. eCollection 2020.

本文引用的文献

1
Relevance of high and low penetrance.高外显率和低外显率的相关性。
Lancet. 2001 Jul 28;358(9278):331-2. doi: 10.1016/S0140-6736(01)05506-4.
2
Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.UGT1A1基因多态性与乳腺癌及血浆激素水平的关联。
Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):711-4.
3
Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.类固醇代谢基因CYP17多态性与乳腺癌的发生发展
Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8.
4
The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue.谷胱甘肽S-转移酶M1基因型与乳腺组织中多环芳烃-DNA加合物之间的关联。
Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1079-85.
5
N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.绝经后女性中N-乙酰基转移酶-2基因多态性、熟肉摄入量与乳腺癌风险
Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):905-10.
6
Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.细胞色素P450 1B1(CYP1B1)药物遗传学:多态性与雌激素羟化活性功能差异的关联
Cancer Res. 2000 Jul 1;60(13):3440-4.
7
Genetic and hormonal risk factors in breast cancer.乳腺癌的遗传和激素风险因素。
J Natl Cancer Inst. 2000 Jul 19;92(14):1126-35. doi: 10.1093/jnci/92.14.1126.
8
Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers.I1307K APC突变与遗传性和散发性乳腺癌/卵巢癌的关联:问题多于答案。
Br J Cancer. 2000 Jul;83(2):153-5. doi: 10.1054/bjoc.2000.1248.
9
Low penetrance genes associated with increased risk for breast cancer.与乳腺癌风险增加相关的低外显率基因。
Eur J Cancer. 2000 Jun;36(10):1193-9. doi: 10.1016/s0959-8049(00)00082-4.
10
Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk.饮酒、谷胱甘肽S-转移酶M1和T1基因多态性与乳腺癌风险
Pharmacogenetics. 2000 Jun;10(4):301-9. doi: 10.1097/00008571-200006000-00004.